Dr. Richard Merkin is renewing support for transformative research at the Broad Institute.
For more than a decade, Merkin has supported research at the Broad, enabling scientists to develop new genome-editing technologies, gain insight into how DNA is organized in cancer cells, and devise methods for discerning the function of genetic variants. Through the Merkin Institute Fellowship, he has helped nearly 20 promising early career scientists gain experience, drive impact, and launch innovative research. Most recently, he supported the founding of the Merkin Institute for Transformative Technologies in Healthcare at the Broad Institute, an initiative whose mission is to realize the potential for innovations in biomedicine – specifically, technologies meant to have a profound effect on therapeutics, diagnostics, and data. He also established the Richard Merkin Professorship, an endowed professorship currently held by Broad Institute Core Member David Liu.
